Stock listing

KRX:207940 Samsung Biologics Co., Ltd. (삼성바이오로직스) 주가

Follow Samsung Biologics Co., Ltd. into a list and get an email when it puts out news.

Share price · KRX:207940

₩1,298,000 KRW +51,000 (+4.1%)

Close on Oct 16, 2026

Samsung Biologics Co., Ltd. logo
Ticker
KRX:207940
Asset type
Stock
Exchange
KRX
Currency
KRW

What changed lately

Latest news

PolyPeptide Group: Provisional interim result of the public tender offer of Samsung Biologics Co., Ltd.

Oct 13, 2026

Samsung Biologics publishes prospectus for PolyPeptide public tender offer

Aug 31, 2026

Samsung Biologics Reports Second Quarter 2026 Financial Results

Jul 23, 2026

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Jul 19, 2026

Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth

Jun 30, 2026

2025 FY Audited Financial Statements (Consolidated)

May 20, 2026

Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline

May 6, 2026

Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year

May 5, 2026

Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific

Apr 29, 2026

Samsung Biologics Reports First Quarter 2026 Financial Results

Apr 22, 2026

All Samsung Biologics Co., Ltd. news

Samsung Biologics Co., Ltd. on 6ix

News releases
23 in the last 12 months · 30 in all · newest Oct 13, 2026 · oldest 2025

Log in to ask 6ix AI your own questions about Samsung Biologics Co., Ltd.